Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

NCT ID: NCT00596180

Last Updated: 2017-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropsychiatric Sequelae of Carbon Monoxide Poisoning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

HBOT

HBOT

Intervention Type DRUG

total body exposure to greater than atmospheric pressure oxygen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HBOT

total body exposure to greater than atmospheric pressure oxygen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria

* None.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Harch Hyperbaric Research Foundation

OTHER

Sponsor Role collaborator

Paul G. Harch, M.D.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul G. Harch, M.D.

Clinical Professor of Medicine

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul G Harch, M.D.

Role: PRINCIPAL_INVESTIGATOR

LSU School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Family Physicians Center

Marrero, Louisiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul G Harch, M.D.

Role: CONTACT

504-309-4948

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paul G Harch, M.D.

Role: primary

504-309-4948

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LSU IRB #6626

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hyperbaric Treatment of Traumatic Brain Injury (TBI)
NCT01847755 COMPLETED PHASE1/PHASE2
Inhaled Nitric Oxide in Brain Injury
NCT03260569 COMPLETED PHASE3
Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy
NCT06574048 NOT_YET_RECRUITING PHASE1/PHASE2